Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

19 trials with published results (12%)

Research Maturity

114 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.3%

7 terminated out of 162 trials

Success Rate

94.2%

+7.7% vs benchmark

Late-Stage Pipeline

26%

42 trials in Phase 3/4

Results Transparency

17%

19 of 114 completed with results

Key Signals

19 with results94% success

Data Visualizations

Phase Distribution

119Total
Not Applicable (41)
Early P 1 (1)
P 1 (12)
P 2 (23)
P 3 (19)
P 4 (23)

Trial Status

Completed114
Unknown31
Terminated7
Recruiting5
Withdrawn4
Suspended1

Trial Success Rate

94.2%

Benchmark: 86.5%

Based on 114 completed trials

Clinical Trials (162)

Showing 20 of 20 trials
NCT05884866Phase 2CompletedPrimary

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

NCT03376282Not ApplicableTerminatedPrimary

Hyperbaric Oxygen Therapy for Renal Regeneration in Diabetic Nephropathy

NCT06492031CompletedPrimary

Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients

NCT06096142Not ApplicableRecruiting

The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion

NCT07058909Not ApplicableCompleted

Premarket Clinical Safety Assessment of the ELISIO™-HX

NCT06909968Completed

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

NCT01312727Not ApplicableCompleted

Hereditary Tubulointerstitial Nephritis

NCT04700631Not ApplicableCompletedPrimary

Extracellular Vesicles as Biomarkers for Chronic Renal Failure

NCT01220843Phase 3CompletedPrimary

FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease

NCT01202708Not ApplicableCompletedPrimary

Gambro AK200 ULTRA Hemodiafiltration Study

NCT01903213CompletedPrimary

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

NCT03302546Not ApplicableCompletedPrimary

Incremental Hemodialysis as a Starting Way of Renal Replacement Therapy

NCT06347029Not ApplicableRecruitingPrimary

Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies

NCT06259266Not ApplicableWithdrawnPrimary

Catheter Dysfunction Rate in Patients Undergoing Kidney Replacement Therapy. Evaluation of the Safety and Efficacy of Anti-reflux Valves Without Heparin Lock Solution

NCT06227468Recruiting

A Clinical Study to Map the HLA Genomic Region in the Greek Population

NCT04952506Phase 1CompletedPrimary

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04697459Not ApplicableCompletedPrimary

Chronic Intradialytic Exercise : a Cardioprotective Role

NCT04525196Not ApplicableUnknownPrimary

Physical Activity in Dialysis: Clinical and Biological Impact

NCT06046261Not ApplicableCompleted

Exploring the Impact of " ACP Board Game for Life" on Death Preparation and Anxiety in Patients With Stage 4 and 5 Chronic Kidney Diseases: A Pilot Study

NCT04085094CompletedPrimary

Gender Differences in Renal Functioning and Disease

Scroll to load more

Research Network

Activity Timeline